Is Venus Protocol a Good Investment?
| TVL | $1.2B |
| FDV | $79M |
| TVL/FDV | 15.20x |
| Risk Grade | C |
| Value Grade | C+ |
Value Accrual: Does the Venus Protocol Token Capture Value?
Venus Protocol scores C+ on Hindenrank's value accrual framework (54/100), indicating average value capture — some strengths offset by weaknesses in fee distribution or sustainability. Fee capture scores 16/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is rated 12/25 (somewhat concentrated, raising concerns about governance capture), and emission sustainability sits at 14/25. The competitive moat dimension scores 12/25.
Protocol Health: Is Venus Protocol Still Growing?
Venus Protocol's vitality risk score is 4/10 on Hindenrank's rubric (lower is healthier). This suggests moderate health — Venus Protocol is maintaining activity but may be showing signs of plateauing growth or reduced developer engagement. The protocol is functional but may not be accelerating.
Risk-Adjusted View: Is the Upside Worth the Risk?
Risk-Adjusted Position
NeutralVenus Protocol sits in the Neutral zone — average on both risk (C) and value (C+). There is no strong reason to overweight or avoid the token at current levels. Monitor for catalysts that could shift the balance in either direction.
Risk Context
Venus Protocol carries a risk grade of C (50/100), classified as elevated risk — multiple novel mechanisms and notable interaction risks. The protocol has 1 critical interaction risk that investors should monitor carefully. The primary risk factor is: History of severe incidents: $200M+ XVS price manipulation cascade (2021), $100M+ bad debt from BNB bridge hack (2022), and a March 15, 2026 donation attack extracting $3.7M via supply cap manipulation (attacker accumulated 12.2M THE tokens over 9 months to bypass supply limits)
Read our full safety analysis →Where Venus Protocol Sits Among Lending Peers
On risk, Venus Protocol ranks #84 of 90 Lending protocols (bottom quartile — among the riskiest). That's 13 points riskier than the sector average of 37/100.
The closest peer by risk profile is Amber Finance (grade C, 48/100). See the side-by-side comparison to weigh their tradeoffs.
Should you buy Venus Protocol?
Venus Protocol scores C+ on Hindenrank's value accrual framework, placing it among the average Lending protocols. Fee capture scores 16/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is somewhat concentrated, raising concerns about governance capture, and emission sustainability sits at 14/25. On the risk side, Venus Protocol carries a C grade (50/100), which is elevated risk — multiple novel mechanisms and notable interaction risks. The combined risk-value position places Venus Protocol in the Neutral quadrant.
Venus Protocol investment outlook for 2026
With $1.2B in total value locked and FDV of $79M, giving a TVL/FDV ratio of 15.20, Venus Protocol's fundamentals do not strongly support the current valuation from a usage perspective. The competitive moat dimension scores 12/25, suggesting meaningful but not impregnable competitive advantages.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.
This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology
Weekly Commentary
ProWeek of April 1, 2026
Venus sits comfortably in the neutral zone—a C risk grade reflects moderate exposure to both smart contract and market dependency risks, while the C+ value score suggests modest but real fee accrual to token holders. At $1.1B TVL, it's large enough to matter in lending but not insulated from tail risks that could swing the risk profile sharply. The middle ground makes Venus a hold-not-buy: the risk-adjusted returns don't pull you in, but the grade decay isn't screaming exit either.
Exploring options?
Compare Lending Alternatives →Related Lending Investment Analyses
Related Lending Safety Analyses
Get risk alerts before it's too late
Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.